It is time to adapt anti-CD20 administration schedules to allow efficient anti-SARS-CoV-2 vaccination in patients with lymphoid malignancies

Detalles Bibliográficos
Autor principal: Besson, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883560/
https://www.ncbi.nlm.nih.gov/pubmed/34320792
http://dx.doi.org/10.3324/haematol.2021.279457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883560/
https://www.ncbi.nlm.nih.gov/pubmed/34320792
http://dx.doi.org/10.3324/haematol.2021.279457

Ejemplares similares